We are live on ! Find out more
LFMD icon

LifeMD

106 hedge funds and large institutions have $79.3M invested in LifeMD in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more call options, than puts

Call options by funds: $775K | Put options by funds: $476K

50% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 26

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

5% more funds holding

Funds holding: 101106 (+5)

2.81% less ownership

Funds ownership: 39.82%37.01% (-2.8%)

12% less capital invested

Capital invested by funds: $89.9M → $79.3M (-$10.6M)

Holders
106
Holders Change
+5
Holders Change %
+4.95%
% of All Funds
1.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
39
Reduced
26
Closed
16
Calls
$775K
Puts
$476K
Net Calls
+$299K
Net Calls Change
-$106K

LFMD Hedge Fund Activity: Q4 2024 in Review

106 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q4 2024, worth a combined $79.3M — down 12% from $89.9M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new LFMD positions and 16 closed out — a net gain of 6 holders — while 39 added to existing stakes and 26 trimmed.

The largest buyer was Marshall Wace, adding an estimated $1.63M. The largest seller was Divisadero Street Capital Management, exiting entirely with an estimated $7.9M sold.

  • 106 institutional investors held LifeMD (LFMD) as of Q4 2024, up from 101 in Q3 2024.
  • Funds reported $79.3M of LifeMD stock for Q4 2024, down 12% quarter-over-quarter.
  • 22 funds opened new LifeMD positions in Q4 2024 and 16 closed out, a net change of +6 holders.
  • The largest LifeMD buyer in Q4 2024 was Marshall Wace, an estimated $1.63M added.
  • The largest LifeMD seller in Q4 2024 was Divisadero Street Capital Management, an estimated $7.9M sold.

Based on aggregated 13F filings for Q4 2024.